engcon AB (publ) (FRA:917)
Germany · Delayed Price · Currency is EUR 6.73
+0.10 (1.51%)
At close: Aug 1, 2025, 10:00 PM CET
Intra-Cellular Therapies Market Cap
engcon AB has a market cap or net worth of €1.04 billion as of August 1, 2025. Its market cap has decreased by -14.26% in one year.
Market Cap
1.04B
Enterprise Value
1.05B
Revenue
159.48M
Ranking
n/a
PE Ratio
49.36
Stock Price
$6.73
Market Cap Chart
Since June 17, 2022, engcon AB's market cap has increased from 1.02B to 1.04B, an increase of 1.12%. That is a compound annual growth rate of 0.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 1.05B | -24.38% |
| Dec 30, 2024 | 1.39B | 9.06% |
| Dec 29, 2023 | 1.27B | 40.10% |
| Dec 30, 2022 | 906.75M | -11.46% |
| Jun 17, 2022 | 1.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 292.08B |
| Siemens Aktiengesellschaft | 174.92B |
| Deutsche Telekom AG | 153.20B |
| Allianz SE | 132.59B |
| Siemens Energy AG | 80.60B |
| Rheinmetall AG | 79.52B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.53B |
| Deutsche Bank Aktiengesellschaft | 55.70B |